Our Approach
Treatments
Resources
- Blog
- Research
Press & Media
Contact Us
Make A Payment
Book an Appointment
(847) 243-6041

PRI HIPAA Privacy Practices Notice

Coming soon

Terms of Use | HIPAA Privacy Practices Notice

Amniotic Fluid, Amniotic Derived and Wharton’s Jelly products are classified by the Food and Drug Administration (FDA) as Human Cell, Tissue and Cellular and Tissue-Based Products (HCT/P) that are regulated solely under section 361 of the Public Health Service (PHS) Act. FDA recognizes that human tissue was designed, or evolved, to perform certain functions in the human body with exquisite safety and effectiveness. As an HCT/P regulated solely under Section 361 of the PHS Act, these products are exempt from FDA pre-market review, clearance, and approval from FDA. Please consult your doctor to see if an amniotic fluid injection is right for you. No medical advice has been offered herein. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. Results may vary.

Digital Millennium Copyright Act (DMCA)

For Digital Millennium Copyright Act (DMCA)
Take-down Requests per 17 U.S. Code § 512

DMCA AGENT, Matthew T. Bullock, Pradica
1415 W. 22nd Street, Tower Floor
Oakbrook, IL 60523
727-808-9181
Email | Website

DMCA Registration #: DMCA-1029623

Privacy Preference Center

Privacy Preferences

Take this 30 Second Quiz

Oops! We could not locate your form.